• Filing Date: 2013-04-12
  • Form Type: 10-K
  • Description: Annual report
v2.4.0.6
INTANGIBLE ASSETS PATENTS (Details) (USD $)
Dec. 31, 2011
Sep. 29, 2009
Sep. 17, 2009
Merger Agreement common stock issued     4,500,000
Pharma Tech to sell a minimum of the product each year     $ 500,000
BioPharma transaction intangible asset recorded in the amount     4,187,815
Common share issued on the date of acquisition par value per share     $ 0.93
Agreement resulting in an impairment 3,208,372    
Accumulated amortization as of 418,782    
Intangible asset, net of acumulated amorization as of 37,185    
Balance of the intangible asset amortized 27,044    
Common stock issued for patent   500,000  
Legal fees Payable amount   47,595  
Patent recorded an intangible asset   462,715  
Shares issued per share value   $ 0.93  
Assumed liability   $ 47,595